Exploring Equity in Diagnosis | Nov. 18-19, 2024 | Chicago, USA, and Online
AAIC® Advancements: Exploring Equity in Diagnosis aims to advance science and collaboration around identifying, understanding and addressing disparities in an era of biomarker-based diagnosis for Alzheimer’s disease and other dementias. This two-day conference will bring together leaders from across disciplines, including academia, industry, philanthropy and government.
As science advances and evolves, it’s critical that we understand and address how disparities play a role in dementia diagnosis. From ethics in diagnosis disclosure to issues of inequity within health systems, this meeting will address some of the big questions that come along with creating equity in diagnostic practices.
All are invited to submit abstracts and share research findings and key learnings about best practices, current and future challenges for equitable diagnosis of Alzheimer’s disease and related dementias.
Abstract themes will be aligned with the Health Disparities Framework and its four levels of analysis:
Read the full guidance for submitting an abstract (PDF).
Multiple Principal Investigators: Maria C. Carrillo, Gladys Maestre and Lycia Neumann.
*Ex-Officio Member
Companies interested in sponsoring AAIC Advancements: Exploring Equity in Diagnosis can contact the corporate initiatives team at corporateinitiatives@alz.org.
AAIC Advancements: Exploring Equity in Diagnosis aims to provide a safe, equitable, and accessible experience for all conference participants.
Read the full Statement of Appropriate Conduct (PDF).
General questions: healthequity@alz.org
Media questions: media@alz.org
Dates: Nov. 18-19, 2024
Location:
Swissotel Chicago, USA, and online
Cost:
A limited number of conference fellowships are available. You can apply for a fellowship during the abstract submission process.
Network and collaborate year-round with ISTAART, a global community of scientists, clinicians and dementia professionals who are working to advance Alzheimer’s and dementia research and treatment.
We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.